Metastatic castration-resistant prostate cancer: The emerging continuum of care

Can Urol Assoc J. 2013 Jan-Feb;7(1-2 Suppl 1):S3. doi: 10.5489/cuaj.229.

Author

Fred Saad¹

Affiliation

¹ Chairman, National Cancer Institute of Canada Clinical Trials Genitourinary Group (NCIC-CTG G-U) and Canadian Urologic Oncology Group (CUOG); Professor and Chief of Urology, Director of Urologic Oncology, Endowed Chair in Prostate Cancer, Centre Hospitalier de l'Université de Montréal, Montreal, QC.

No abstract available